FY results were ahead of expectations, with a strong closing month. It has seen a strong recovery in nearly all its end markets, with some internal efficiency benefits gained and exceeding some currency headwinds and supply chain challenges. No change to forecasts with recovery expected to continue, underwritten by a growing order book, and management is cautiously positive. Our price target remains 1450p, offering upside after its recent underperformance.
